Log on / register
Feedback | Support | My details
Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients.
Sassen A, Rochon J, Wild P, Hartmann A, Hofstaedter F, Schwarz S, Brockhoff G
Breast Cancer Res 2008, 10:R2
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research article
Presence of HER4 associates with increased sensitivity to Herceptin in patients with metastatic breast cancer
Sassen A, Diermeier-Daucher S, Sieben M, Ortmann O, Hofstaedter F, Schwarz S, Brockhoff G
Breast Cancer Research 2009, 11:R50 (22 July 2009)
[Full text] [PubMed Central] [PubMed] [Related articles]
2.


Research article
Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors
Frogne T, Laenkholm AV, Lyng MB, Henriksen KL, Lykkesfeldt AE
Breast Cancer Research 2009, 11:R11 (24 February 2009)
[Full text] [PubMed Central] [PubMed] [Related articles] [Cited on BioMed Central]

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.